Viewing Study NCT05740566


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2026-01-01 @ 2:58 PM
Study NCT ID: NCT05740566
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-03
First Post: 2023-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module